Evaluation of screening practices for primary hyperaldosteronism by specialists and general practitioners: an observational, cross-sectional study
Open Access
- 22 March 2024
- journal article
- research article
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 68, e230211
Abstract
Objective: Despite its recognized importance, primary hyperaldosteronism (PHA) remains an underdiagnosed condition in clinical practice. The objective of the present study was to evaluate PHA screening practices by general practitioners and specialists in endocrinology and cardiology. Subjects and methods: This cross-sectional, observational study invited physicians to respond voluntarily to an online survey. The survey collected the respondents’ sociodemographic data and answers to five hypothetical clinical cases meeting Endocrine Society criteria for PHA screening. Results: In all, 126 physicians responded [...] ABSTRACT Objective: Despite its recognized importance, primary hyperaldosteronism (PHA) remains an underdiagnosed condition in clinical practice. The objective of the present study was to evaluate PHA screening practices by general practitioners and specialists in endocrinology and cardiology. Subjects and methods: This cross-sectional, observational study invited physicians to respond voluntarily to an online survey. The survey collected the respondents’ sociodemographic data and answers to five hypothetical clinical cases meeting Endocrine Society criteria for PHA screening. Results: In all, 126 physicians respondedKeywords
This publication has 20 references indexed in Scilit:
- Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort StudyHypertension, 2021
- Progress in Primary Aldosteronism 2019: New Players on the Block?Hormone and Metabolic Research, 2020
- Screening Rates for Primary Aldosteronism in Resistant HypertensionHypertension, 2020
- Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensivesSurgery, 2019
- Diagnosis and treatment of primary aldosteronism: practical clinical perspectivesJournal of Internal Medicine, 2018
- Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysisThe Lancet Diabetes & Endocrinology, 2018
- Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort studyThe Lancet Diabetes & Endocrinology, 2018
- The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives ∗JACC, 2017
- Guidelines for primary aldosteronismJournal Of Hypertension, 2016
- A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive PatientsJACC, 2006